Wall Street Zen cut shares of Composecure (NYSE:GPGI – Free Report) from a sell rating to a strong sell rating in a research report report published on Sunday.
A number of other equities analysts have also issued reports on the stock. JPMorgan Chase & Co. reduced their price target on shares of Composecure from $22.00 to $15.00 and set a “neutral” rating for the company in a research report on Friday, May 15th. Zacks Research lowered shares of Composecure from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, July 14th. Finally, Weiss Ratings reiterated a “sell (d-)” rating on shares of Composecure in a research note on Thursday, June 11th. One analyst has rated the stock with a Buy rating, two have issued a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus target price of $15.00.
Check Out Our Latest Analysis on Composecure
Composecure Trading Up 2.6%
Composecure (NYSE:GPGI – Get Free Report) last announced its quarterly earnings data on Thursday, May 7th. The company reported $0.12 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.09 by $0.03. The firm had revenue of $421.20 million during the quarter. During the same period last year, the firm posted $0.25 EPS. Analysts expect that Composecure will post 0.9 EPS for the current fiscal year.
Composecure Announces Dividend
The firm also recently declared a quarterly dividend, which was paid on Monday, June 1st. Shareholders of record on Monday, May 18th were given a dividend of $0.0025 per share. The ex-dividend date was Monday, May 18th. This represents a $0.01 dividend on an annualized basis and a yield of 0.1%. Composecure’s dividend payout ratio is currently -0.42%.
Insider Buying and Selling
In other Composecure news, Director Kevin M. Moriarty acquired 3,956 shares of the business’s stock in a transaction dated Tuesday, May 26th. The stock was acquired at an average cost of $12.64 per share, for a total transaction of $50,003.84. Following the completion of the transaction, the director directly owned 71,011 shares of the company’s stock, valued at $897,579.04. This represents a 5.90% increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Thomas R. Knott acquired 85,250 shares of the business’s stock in a transaction dated Thursday, June 11th. The stock was acquired at an average price of $11.67 per share, with a total value of $994,867.50. Following the completion of the transaction, the insider directly owned 129,250 shares of the company’s stock, valued at approximately $1,508,347.50. This represents a 193.75% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. Insiders acquired 105,237 shares of company stock valued at $1,245,734 in the last 90 days. Corporate insiders own 18.40% of the company’s stock.
About Composecure
CompoSecure, Inc manufactures and designs metal, plastic, composite ID, and proprietary financial transaction cards in the United States and internationally. Its primary metal form factors include embedded, metal veneer lite, metal veneer, and full metal products. The company also offers Arculus Cold Storage Wallet, a three-factor authentication solution, which comprise the Arculus Key card Cold Storage hardware device and companion Arculus Wallet mobile App to keep the Private Key in the Arculus Key card highly secure and store cryptocurrency and digital assets.
Featured Stories
- Five stocks we like better than Composecure
- These 3 Stocks Have Soared in 2026—Can They Keep Climbing?
- Hasbro’s Earnings Beat Shows Why This Is No Longer Just a Toy Story
- Rambus: Another AI Phoenix Ready to Rise From the Ashes of Correction
- Chips & Clips: Memory Tariffs Rewire Tech Supply Chains
Receive News & Ratings for Composecure Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Composecure and related companies with MarketBeat.com's FREE daily email newsletter.
